Known targets — ChEMBL curated mechanism
ABCC8ACEADORA1ADORA2AADORA2BADORA3ALDH5A1ALOX5ALOX5APATP4AATP4BBRAFCA1CA12CA2CA4CYSLTR1DHFRDPEP1EDNRAEDNRBESR2F10FDPSFGF1GABBR1GABBR2GABRA1GABRA2GABRA3GABRA4GABRA5GABRA6GABRB1GABRB2GABRB3GABRDGABREGABRG1GABRG2GABRG3GABRPGABRQGARTGNRHRGSC1HMGCRIMPDH1IMPDH2KCNJ11LY96NOD2NR3C1NS3NS4ANS5bP2RY1P2RY12P2RY2P2RY4P2RY6PBP2XPDE3APDE3BPDE4APDE4BPDE4CPDE4DPDK1PDK2PDK3PDK4PPARGPPATPTGIRPTGS1PTGS2RAF1RYR1RYR3SCN10ASCN11ASCN1ASCN2ASCN3ASCN4ASCN5ASCN7ASCN8ASCN9ASERPINC1SLC12A1SLC12A3SYKTHRATHRBTLR3TLR4TLR9TUBA1ATUBA1BTUBA1CTUBA3CTUBA3ETUBA4ATUBBTUBB1TUBB2ATUBB2BTUBB3TUBB4ATUBB4BTUBB6TUBB8TYMSVKORC1XDHblablaIMP-1blaOXA-33blaOXA-58blaT-3blaT-4blaT-5blaT-6dacAdacBdacCfolAfolPfolP1ftsIfusAgaggyrAgyrBmecAmrcAmrcBmrdApbp1apbp1bpbp2pbp2apbp2bpbp3pbp4pbpApbpBpbpCpbpFpolponBrplArplBrplCrplDrplErplFrplJrplKrplLrplMrplNrplOrplPrplQrplRrplSrplTrplUrplVrplWrplXrplYrpmArpmBrpmCrpmDrpmErpmFrpmGrpmHrpmIrpmJrpoArpoBrpoCrpoZrpsArpsBrpsCrpsDrpsErpsFrpsGrpsHrpsIrpsJrpsKrpsLrpsMrpsNrpsOrpsPrpsQrpsRrpsSrpsTrpsUykgMykgO
The experimentally established mechanism targets of 2,3-Dimercapto-1-Propanesulfonic Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SLC22A6 | Q4U2R8 | 1/20 | 0.54 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.42 |
| ▸ | MAPT | P10636 | 1/20 | 0.42 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.42 |
| ▸ | ENPEP | Q07075 | 2/20 | 0.41 |
| ▸ | NR1I2 | O75469 | 1/20 | 0.33 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.33 |
| ▸ | LMNA | P02545 | 1/20 | 0.33 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.33 |
| ▸ | HTT | P42858 | 1/20 | 0.33 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.33 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| 2,3-Dimercapto-1-Propanesulfonic Acid SCHEMBL27233595 | 1.00 | SLC22A6 (0.54) | SLC22A6KDM4EMAPTALOX15ENPEP | |
| 2,3-Dimercapto-1-Propanesulfonic Acid SCHEMBL1200081 | 0.97 | SLC22A6 (0.52) | SLC22A6KDM4EMAPTALOX15ENPEP | |
| 2,3-Dimercapto-1-Propanesulfonic Acid SCHEMBL27877302 | 0.95 | SLC22A6 (0.54) | SLC22A6KDM4EMAPTALOX15ENPEP | |
| 2,3-Dimercapto-1-Propanesulfonic Acid SCHEMBL7780962 | 0.95 | SLC22A6 (0.54) | SLC22A6KDM4EMAPTALOX15ENPEP | |
| SCHEMBL14989014 | 0.77 | KDM4E (0.35) | SLC22A6KDM4EMAPTALOX15ENPEP | |
| SCHEMBL27426173 | 0.75 | — | — | |
| SCHEMBL4430233 | 0.72 | ENPEP (0.40) | SLC22A6KDM4EMAPTALOX15ENPEP | |
| 2,3-Dimercapto-1-Propanesulfonic Acid SCHEMBL17744957 | 0.70 | — | — | |
| SCHEMBL1578142 | 0.70 | — | — | |
| 2,3-Dimercapto-1-Propanesulfonic Acid SCHEMBL20483588 | 0.70 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Appears in 2486 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-116909287-B | Vehicle lane changing obstacle avoidance track planning method integrating DMPs and APF | TONGJI UNIVERSITY (CN) | 2026-05-26 | — | — | CN | claimed |
| EP-4739992-A1 | DETECTION OF TARGET MOLECULES IN DRIED BIOLOGIC MATRICES | SomaLogic Operating Co., Inc. (US) | 2026-05-13 | — | — | EP | claimed |
| CN-122013272-A | HVLP copper foil electroplating process | 江西鑫铂瑞科技股份有限公司 | 2026-05-12 | — | — | CN | claimed |
| EP-4734964-A1 | LIPID PARTICLES FOR DELIVERING A PAYLOAD | Repertoire Immune Medicines, Inc. (US) | 2026-05-06 | — | — | EP | claimed |
| WO-2026090590-A1 | NANOPARTICLE FORMULATIONS FOR THE DELIVERY OF DNA TO ADIPOSE TISSUE | Remedium Bio, Inc. (US) | 2026-04-30 | — | — | WO | claimed |
| US-20260054227-A1 | COMPOSITE MEMBRANE AND METHOD OF MAKING THE SAME | H2MO TECH PTE LTD (SG) | 2026-02-26 | — | — | US | claimed |
| EP-4687845-A1 | PEGYLATED ORGANELLE COMPLEXES | LUCA Science Inc. (JP) | 2026-02-11 | — | — | EP | claimed |
| US-20260029400-A1 | GAS-FILLED MICROVESICLES WITH LIGAND | BRACCO SUISSE SA (CH) | 2026-01-29 | — | — | US | claimed |
| EP-4676514-A1 | NANODISCS FOR USE IN REMOVING LIPID ACCUMULATION IN THE EYE | Mobius Scientific Inc. (US) | 2026-01-14 | — | — | EP | claimed |
| US-12514938-B2 | Fibroblast activation protein targeting peptides | PERSPECTIVE THERAPEUTICS, INC. (US) | 2026-01-06 | — | — | US | claimed |
| WO-2004017957-A1 | PREVENTING AND/OR TREATING CARDIOVASCULAR DISEASE AND/OR ASSOCIATED HEART FAILURE | PROTEMIX CORPORATION LIMITED (NZ) | 2004-03-04 | — | — | WO | claimed |
| US-20030203973-A1 | Preventing and/or treating cardiovascular disease and/or associated heart failure | PHILERA NEW ZEALAND LIMITED (NZ) | 2003-10-30 | — | — | US | claimed |
| US-20030190315-A1 | Treatment of atherosclerotic disorders | CAMNUTRA LIMITED (GB) | 2003-10-09 | — | — | US | claimed |
| WO-2003077901-A1 | PREVENTING AND/OR TREATING CARDIOVASCULAR DISEASE AND/OR ASSOCIATED HEART FAILURE | PROTEMIX CORPORATION LIMITED (NZ) | 2003-09-25 | — | — | WO | claimed |
| WO-2003075910-A1 | PREVENTING AND/OR TREATING VASCULAR DISEASE, CARDIOMYOPATHY AND/OR ASSOCIATED HEART FAILURE | PROTEMIX CORPORATION LIMITED (NZ) | 2003-09-18 | — | — | WO | claimed |
| WO-2003017992-A2 | MEANS FOR TREATMENT OF ATHEROSCLEROSIS | CAMBRIDGE THERANOSTICS LTD (GB) | 2003-03-06 | — | — | WO | claimed |
| US-5421897-A | Applying liquid composition to surface contaminated with lead, solidifying into matrix which sequesters lead, removing matrix | GRAWE JOHN (US) | 1995-06-06 | — | — | US | claimed |
| EP-0248735-B1 | 2-Thiazolyl imidazo [1,2-a] pyrimidines and their salts, process for their preparation, their use as medicaments and compositions containing them | ROUSSEL-UCLAF (FR) | 1990-05-23 | — | — | EP | claimed |
| US-4382040-A | REACTING ALLYL HALIDE WITH A SULFITE, BROMINATION, REACTING WITH SODIUM HYDROGEN SULFIDE, FORMING A METAL COMPLEX AND REACTING WITH HYDROGEN SULFIDE | HEYL & CO. (DE) | 1983-05-03 | — | — | US | claimed |
| EP-0024562-A1 | Process for the preparation of 2,3-dimercaptopropane-1-sulfonic acid and its salts | Heyl Chemisch-pharmazeutische Fabrik GmbH & Co. KG (DE) | 1981-03-11 | — | — | EP | claimed |